Skip to main content
Equibles
IRTC logo

IRTC · iRhythm Holdings, Inc. · Metrics

Track IRTC — free

Use IRTC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRTC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$113.55 -0.30 (-0.26%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$3.74B
Shares
32.96M
Volume · Oct 21 424.32K Avg daily vol (3M) 564.95K

IRTC metrics

94 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$113.55
Market cap
$3.74B

Price action

20 metrics
Price change (1W)
+7.1%
Price change (30D)
+2.7%
Price change (3M)
+7.1%
Price change (6M)
-6.9%
Price change (YTD)
-36.0%
Price change (1Y)
-36.3%
Trailing year
Price change (5Y)
+61.2%
52-week high
$189.25
52-week low
$101.79
Change from 52-week high
-40.0%
Change from 52-week low
+11.6%
Annualized volatility
43.4%
Annualized volatility (3M)
42.9%
Beta
0.6
RSI (14D)
55.6
Price vs SMA 50
-1.3%
Price vs SMA 200
-8.6%
Avg volume (3M)
564,954
Relative volume
0.8
Average dollar volume
$66.22M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
32.96M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.6×
reciprocal yield 21.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.5×
reciprocal yield 22.1%
P / book
20.1
reciprocal yield 5.0%
FCF yield
1.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
96.0
reciprocal yield 1.0%
P / operating cash flow
43.5
reciprocal yield 2.3%
Earnings yield
-0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.1×
reciprocal yield 16.3%
EV / revenue historical average (5Y)
7.3×
reciprocal yield 13.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
71.5%
Operating margin
-3.0%
Trailing 12 months
Net margin
-1.7%
Gross profit (TTM)
$589.74M
Operating profit (TTM)
−$24.87M
Net income (TTM)
−$13.95M
Trailing 12 months
Diluted EPS (TTM)
$-0.42
FCF margin
4.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$25.42
Gross profit per diluted share (TTM)
$18.16
Operating profit per diluted share (TTM)
$-0.77
EBITDA per diluted share (TTM)
$-0.13
Net income per diluted share (TTM)
$-0.43
Operating cash flow per diluted share (TTM)
$2.64
Free cash flow per diluted share (TTM)
$1.20
Capital expenditures per diluted share (TTM)
$1.45
R&D per diluted share (TTM)
$2.57
Stock compensation per diluted share (TTM)
$2.58
Book value per share
$4.73

Growth

11 metrics
Revenue growth YoY
+20.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$825.34M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.8%
Year over year · more shares
Revenue CAGR (3Y)
+22.1%
Revenue CAGR (5Y)
+23.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-7.5%
Return on assets
-1.3%
Debt / equity
3.5
Current ratio
3.9
EBITDA (TTM)
−$4.27M
Free cash flow (TTM)
$38.98M
Quick ratio
3.7
Interest coverage
-1.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$59.82M
Latest balance sheet
Cash & equivalents
$246.68M
Total assets
$1.09B
Total debt
$651.10M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$86.00M
Capital expenditures (TTM)
$47.02M
R&D (TTM)
$83.28M
SG&A (TTM)
$513.76M
Stock compensation (TTM)
$83.64M
R&D / revenue
10.1%
Stock compensation / revenue
10.1%

Ownership (13F)

9 metrics
13F filers
307
13F filer change QoQ
0
Institutional ownership
108.4%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.3%
Holder tenure
14.3
Price vs estimated holder cost
-8.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.6%

Short interest

3 metrics
Short interest
9.2%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$7.43M
Insider-sentiment score
7 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1388658 CUSIP 450056106 13F (30d) 37 filings 35 filers Visit website Investor relations